Hair Relaxer Cancer Lawsuit: Case Insight and Latest News

Introducing the Hair Relaxer Cancer Lawsuit

Amid growing concerns over the health risks of chemical hair relaxers, more than 9,000 plaintiffs have filed claims against some of the biggest names in the cosmetics industry, making this one of the most significant mass tort cases in recent years.

Companies like L’Oréal, Revlon, and SoftSheen-Carson are accused of selling chemical hair relaxer products containing harmful endocrine-disrupting chemicals (EDCs) without warning consumers about the health risks.

For years, medical research has indicated that these products are capable of interfering with hormone regulation and causing severe reproductive health issues, with prolonged exposure being linked to three different types of cancer.

The issue gained considerable visibility after a 2022 study by the National Institutes of Health (NIH) found that women who frequently used chemical hair straighteners were double as likely to develop uterine cancer compared to non-users. Further research also confirmed links between these products and ovarian and endometrial cancers, providing additional evidence of their long-term health risks. 

The first legal claim against a hair relaxer manufacturer was filed in October 2022, and thousands more followed. Five months later, federal courts consolidated them into a single proceeding known as multi-district litigation (MDL). The MDL is centralized in the Northern District of Illinois under Judge Mary Rowland and now includes nearly 9,800 cases, with more expected to be added. 

Key pretrial proceedings are underway, and the first bellwether trials—test cases that help gauge jury responses—are scheduled for late 2025. These trials can significantly influence the remaining cases and could result in several of them being settled without going to trial.

If you or a loved one has been diagnosed with cancer after using chemical hair relaxers, you may be entitled to compensation. Tosi Law is actively reviewing cases and can help determine if you qualify for legal action.

Contact us today for a free case evaluation.

Find Out if You Qualify For Compensation

If you have been diagnosed with uterine cancer, ovarian cancer, or endometrial cancer and can prove your prolonged use of chemical hair relaxers, you may be eligible to file a lawsuit against the manufacturers. 

Your lawsuit would seek compensation for medical expenses, lost wages, pain and suffering, and other damages you may have suffered as a result of your illness.  

It’s vital to obtain legal input on the specifics of your case. Each lawsuit is evaluated individually, and a legal expert can advise on your eligibility after analyzing the details of your diagnosis, product usage, and any supporting medical records.

If you believe your cancer diagnosis may be linked to chemical hair relaxers, it’s crucial to act quickly. Legal deadlines (statutes of limitations) could affect your lawsuit’s validity.

Contact us today to help us assess your eligibility and to learn more about your legal options.

Article Summary

1. More than 11,000 lawsuits have been filed against major hair relaxer manufacturers like Lóreal and ‎Strength of Nature, alleging a link between their hair relaxer products and uterine, ovarian, and endometrial cancer.
2. Medical research, including a landmark 2022 NIH study, suggests that endocrine-disrupting chemicals in hair relaxers increase the user’s risk of developing cancer, especially with long-term use.
3. A federal judge ruled against manufacturers’ attempts to dismiss the lawsuits, ruling that plaintiffs presented sufficient evidence to support claims that hair relaxer manufacturers failed to warn consumers about potential health risks.
4. In February 2023, federal courts consolidated 9,000 hair relaxer lawsuits into a multi-district litigation(MDL). This streamlines pretrial proceedings, ensures consistency in rulings, and allows plaintiffs to share evidence against the manufacturers.
5. The MDL’s first bellwether trials are scheduled for late 2025 and will serve as test cases to gauge how juries respond to the evidence. Their outcomes could influence settlement negotiations and set important litigation precedents.
6. Since deadlines for filing apply to this lawsuit, it is vital to speak to a law firm if you suspect your cancer diagnosis is related to hair relaxer use. Contact Tosi Law today to discuss your claim’s eligibility.

Latest Hair Relaxer Cancer Case Updates

February 2025

The multidistrict litigation (MDL) centralized in the Northern District of Illinois under Judge Mary Rowland has grown to 9,863 cases. The rapid expansion of this lawsuit is a clear sign that there is now widespread public awareness and legitimate concern over the health risks that these dangerous products pose to women. 

Legal experts predict that the number of filings will continue to rise as more individuals connect their cancer diagnoses with their long-term hair relaxers use. Continued exposure in the media is also helping develop visibility for the case. 

November 1, 2024

The court set two important deadlines for exchanging evidence in the hair relaxer lawsuits. Lawyers must finish collecting and submitting written evidence (internal company documents, medical records, etc.) by February 28, 2025. Witness interviews and testimonies—known as oral discovery—must be completed by September 30, 2025.

These deadlines represent two critical milestones in the case since the evidence they would expose will be crucial in determining the extent to which manufacturers knew about the risks their products posed to consumers. 

The information uncovered during this phase could strengthen plaintiffs’ claims and play a significant role in future settlement negotiations.

November 14, 2023

A federal judge rejected L’Oréal, Revlon, and other manufacturers’ efforts to dismiss these lawsuits. The companies argued that federal regulations on cosmetic safety should take precedence over state-level consumer protection laws, meaning the lawsuits should be dismissed. 

However, Judge Mary Rowland ruled that state law still applies, allowing claims that the manufacturers failed to warn consumers about known cancer risks to move forward.

While some claims were dismissed for lacking specific details, the judge allowed the key allegations to stand, including claims that manufacturers failed to warn consumers about cancer risks and knowingly sold dangerous products. 

Because these claims involve allegations of corporate misconduct rather than product defects, the ruling left room for punitive damages, meaning companies could face substantial financial penalties if found liable.

February 6, 2023

The Judicial Panel on Multidistrict Litigation centralized all hair relaxer cancer lawsuits into an MDL in the Northern District of Illinois, appointing Judge Mary Rowland to oversee proceedings. 

The MDL was created to reduce the duplication of discovery efforts, ensure consistent legal rulings, and streamline pretrial proceedings. This represents a significant milestone in the litigation, transforming what had started as unconnected individual lawsuits into a large-scale, coordinated legal effort.

October 2022

Jenny Mitchell, a 28-year-old woman from Missouri, filed the first lawsuit against L’Oréal USA, Inc. and other manufacturers, alleging that they failed to warn consumers about the cancer risks their products carried.

Ms. Mitchell stated that she had used hair relaxer products since she was 10 years old and was unaware of their potential risks. Her lawsuit became the foundation for an influx of additional cases, with thousands of other women coming forward with similar claims.

Table of Contents

TBD

A Closer Look at Hair Relaxers and Their Health Risks

What is Hair Relaxer and What is It Used For?

Hair relaxers are chemical treatments designed to permanently straighten tightly curled or naturally coiled hair. They work by breaking down the disulfide bonds in the hair shaft, which control the hair’s natural shape and texture. Once broken, these bonds do not reform, leaving the hair straight until new growth appears.

The hair relaxers involved in the cancer lawsuits typically fall into two categories:

• Lye-based relaxers work fast and aggressively, breaking down the hair’s natural structure in a relatively short space of time. However, they are harsher on the scalp and can cause burns or irritation if used incorrectly or left on for too long.
• No-lye relaxers are gentler on the scalp but can be harsher on the hair itself. While they reduce the risk of scalp irritation, they tend to leave hair drier and more fragile.

A third type, thio relaxers, uses ammonium thioglycolate to soften the hair’s keratin structure. These products are not a focus of the lawsuits, as they do not typically contain the endocrine-disrupting chemicals (EDCs) linked to cancer risks.

How Often Are Hair Relaxers Used?

Because users need to continue treating new hair with a relaxer, most reapply the product every six to eight weeks. This routine can continue for decades, as many individuals start using relaxers at a young age and continue treatment for the majority of their lives.

Frequency of use depends on factors like hair texture, growth rate, and personal preference, but most users opt for frequent touch-ups to prevent a visible difference between newly grown hair and previously relaxed sections.

Hair relaxers are most commonly applied in salons by professionals, though many people use at-home touch-up kits to maintain their hair’s relaxed look between appointments. Some individuals relax their entire head of hair each time, while others only touch up the roots to avoid excessive chemical exposure to already processed hair. 

Regardless of the application and touch-up method a user chooses, long-term use of hair relaxers means repeated exposure to dangerous chemicals. 

Hair Relaxers and Cancer: A Detailed Breakdown.

Chemical hair relaxers are formulated to change the natural structure of curly or coiled hair, making it straighter and more manageable. To achieve this effect, manufacturers use specific chemicals that effectively break down the hair’s protein bonds while also making the product more marketable and attractive to customers. 

However, some of these ingredients are known endocrine-disrupting chemicals (EDCs), which can interfere with the body’s hormonal system.

• Formaldehyde is a powerful preservative and disinfectant. It helps maintain the hair relaxer’s stability and prevents damage from microbial growth. It also helps break down the hair’s keratin structure to achieve straightening effects.
• Phthalates are added to hair relaxers to make them more flexible, improve their texture, and increase their spreadability. This allows users to apply the product comfortably to their scalp. 
• Parabens serve as preservatives, extending the hair relaxer’s shelf-life.

EDCs can interfere with the endocrine system in several ways:

• Some EDCs mimic natural hormones like estrogen, tricking the body into responding as if there’s more of the hormone than there actually is. This can lead to abnormal cell growth and increase the risk of hormone-sensitive cancers.
• They can block real hormones from doing their job. Certain EDCs attach to hormone receptors but don’t activate them, preventing the body’s natural hormones from working properly. This can disturb your body’s essential internal processes and lead to serious health issues.
• They can unsettle your body’s hormone production and balance by altering hormonal production, transport, and breakdown. This imbalance is a known trigger for an increased cancer risk.

When the body’s hormones function normally, they regulate essential processes like growth and reproductive health. However, EDCs can interfere with these signals by mimicking natural hormones like estrogen or blocking normal hormone function. 

Over time, this disruption can trigger abnormal cell growth, increasing the risk of hormone-sensitive cancers like uterine, endometrial, and ovarian cancer.

Scientific Evidence Linking Hair Relaxers to Cancer

A pivotal study by the National Institutes of Health (NIH) found that women who used chemical hair straightening products were at a higher risk for uterine cancer compared to those who did not use these products. The research indicated that women who reported frequent use of hair straighteners—defined as more than four times in the previous year—were more than twice as likely to develop uterine cancer.

Further research from Boston University’s Black Women’s Health Study reported that long-term use of chemical hair relaxers by postmenopausal Black women was associated with an increased risk of uterine cancer. Specifically, those who used hair relaxers more than twice a year or for more than five years had a greater than 50% increased risk compared to women who never or rarely used them.

Types of Cancer Linked to Hair Straighteners

Uterine Cancer

With almost 70,000 new cases expected in 2025, uterine cancer is one of the most common gynecologic cancers in the United States. The cancer develops in the tissues of the uterus – the reproductive organ where fetal development occurs. Most cases develop in the endometrium, the inner lining of the uterus, when abnormal cells begin to grow uncontrollably and form tumors. 

While the exact causes are unknown, some factors are known to increase a person’s risk of developing uterine cancer. These include age, body weight, genetic predisposition, and prolonged exposure to endocrine-disrupting chemicals like the phthalates, parabens, and cyclosiloxanes found in hair relaxers. 

The NIH study published in 2022 found a strong correlation between hair relaxer use and uterine cancer, particularly among women who had been using these products regularly for a prolonged period of time.

Speaking to the National Institutes of Health, Dr. Alexandra White, head of the NIEHS Environment and Cancer Epidemiology group, said: “We estimated that 1.64% of women who never used hair straighteners would go on to develop uterine cancer by the age of 70; but for frequent users, that risk goes up to 4.05%.”

Uterine cancer symptoms may include abnormal vaginal bleeding (especially after menopause), pelvic pain or pressure, pain during intercourse, and any unusual vaginal discharge.

If detected early, uterine cancer is often treatable through hysterectomy (surgical removal of the uterus), radiation therapy, or hormone-based treatments. However, advanced cases can spread to other organs, requiring more aggressive chemotherapy and medications like lenvatinib (Lenvima) or pembrolizumab (Keytruda).

Endometrial Cancer

Endometrial cancer is the most common form of uterine cancer. It develops in the endometrium, the inner lining of the uterus, and has been strongly linked to hormonal imbalances, especially excess estrogen and the absence of progesterone regulation.

Other factors such as obesity, age, genetic predisposition, and conditions like polycystic ovary syndrome (PCOS) can also increase the risk.

Symptoms like vaginal bleeding, pain during intercourse, and postmenopausal “spotting” typically develop gradually but become more persistent as the cancer continues to develop. Early-stage endometrial cancer is highly treatable, and patients experiencing these symptoms should see a doctor as soon as possible.

When detected early, surgeons often successfully treat endometrial cancer by removing the patient’s uterus (a surgical procedure known as a hysterectomy). If the cancer is not diagnosed in time, doctors typically use radiation therapy, hormone therapy, chemotherapy, or targeted therapy drugs.

Because it’s such a disease, researchers have expressed concerns that exposure to endocrine-disrupting chemicals found in hair relaxers may elevate the user’s risk of developing endometrial cancer. 

These concerns were validated when research proved that hair products commonly used by Black women “showed hormonal activity” that could have serious health implications for their users.

Ovarian Cancer

Ovarian cancer originates in the ovaries, the reproductive glands that produce estrogen and progesterone. Unlike uterine and endometrial cancers, early-stage ovarian cancer is extremely difficult to detect and often develops without noticeable symptoms. Undetected, the cancer can grow and spread to other parts of the body, making it one of the most dangerous gynecologic cancers.

Several risk factors for ovarian cancer have been identified. These include genetic mutations like BRCA1 and BRCA2, a family history of ovarian or breast cancer, age, and the patient’s reproductive history. 

Unlike uterine and endometrial cancers, which often present with abnormal vaginal bleeding, ovarian cancer symptoms (like bloating, abdominal swelling, and pelvic discomfort) are often vague and tend to be mistaken for less severe health conditions.

Treatment for ovarian cancer usually involves surgical removal of the ovaries and surrounding tissues, followed by chemotherapy targeting any remaining cancer cells. In some cases, targeted therapies such as bevacizumab (Avastin) can be used to block the growth of new blood vessels that fuel tumors. Doctors may also prescribe PARP inhibitors like olaparib (Lynparza) for patients with genetic mutations. 

Research has raised concerns about a potential connection between the long-term use of chemical hair relaxers and ovarian cancer. Since ovarian cancer is hormonally influenced, scientists are investigating whether EDCs found in hair straightening products may contribute to an abnormal hormonal environment that is conducive to the development of ovarian cancer. 

A study by Silent Spring Institute detected 45 endocrine disruptors in hair products marketed to Black women, including parabens and phthalates, which are known to interfere with hormone function.

Uterine Fibroids and Hysterectomies

In addition to cancer, chemical hair relaxers have been linked to uterine fibroids – noncancerous growths that develop in the uterus. Research suggests that Black women—who use hair relaxers at a higher rate than other groups—are disproportionately affected by uterine fibroids, leading to higher rates of complications.

Uterine fibroids can cause heavy menstrual bleeding, intense pelvic pain, fertility problems, and complications with pregnancy. In some cases, fibroids may require the patient to undergo a hysterectomy. 

Manufacturer Liability: The Legal Basis For Hair Relaxer Lawsuits

Hair relaxer lawsuits claim that manufacturers either knew or should have known about the potential health risks of their products but failed to warn consumers about these dangers.

Under product liability law, companies that make and sell consumer products must ensure their safety. This includes proper testing and clear warnings about any risks to the customer’s health. If a company fails to disclose known dangers or foreseeable risks, it can be held legally responsible for harm that these products cause.

In the case of hair relaxers, plaintiffs argue that manufacturers should have known about the dangers linked to chemicals like formaldehyde and phthalates—both of which have been associated with hormone disruption and cancer risks—and should have provided proper warnings to consumers.

What Did Manufacturers Know?

It’s very challenging to understand precisely what manufacturers knew about the dangers of their products. But the legal question isn’t “What did they know?” as much as it’s “Did they do enough to research risks that can be reasonably suspected?”

Lawsuits claim that manufacturers had a responsibility to assess the risks associated with their products, yet never adequately researched chemical ingredients that were later linked to hormone disruption and cancer. 

Many of these chemicals, such as formaldehyde and phthalates, had already been studied for their endocrine-disrupting effects, raising concerns about whether manufacturers conducted sufficient safety testing.

While definitive research linking hair relaxers to cancer has only emerged recently, the presence of known endocrine-disrupting chemicals in these products suggests that manufacturers should have been more cautious in their formulations and kept their customers informed about their risks.

Manufacturers and Products Named in the Hair Relaxer Cancer Lawsuit

When a manufacturer or product is named in a lawsuit, they are officially held responsible for harm allegedly caused by their product. In legal terms, this means the company is being accused of failing to warn consumers about risks or selling an unsafe product.

Which Manufacturers and Products Are Named?

The following hair relaxer manufacturers and products have been named in the lawsuits. 

• L’Oreal: Darko and Loverly, Soft and Beautiful, Mizani
• Strength of Nature/Godrej Consumer Products: Just for Me
• Namaste Laboratories/Dabur India: (ORS) Olive Oil Girls
• ‎Strength of Nature: Motions
• Godrej Consumer Products: TCB Naturals
• Dabur India, Ltd: Namaste
• SoftSheen-Carson: Optimum, Just for Me

As more consumers come forward with cases, more hair relaxer products and brands could be added to the lawsuit. If someone has been diagnosed with uterine, ovarian, or endometrial cancer after long-term use of chemical hair relaxers, they may be eligible to join the lawsuit—even if the product they used is not yet listed in the case.

Hair Relaxers and the FDA: A Brief History

In the mid-1990s, Rio Hair Naturalizer System was marketed as a “chemical-free” and “all-natural” hair relaxer. But instead of being safe and gentle, thousands of consumers reported serious side effects, including hair loss, burns, and even an unexpected green tint in their hair.

The FDA received over 3,000 complaints, making it one of the most widely reported cosmetic product issues at the time. When the agency investigated, it found that Rio’s formula contained harsh, acidic chemicals despite its “natural” branding. In January 1995, the FDA issued a strong warning, and soon after, U.S. marshals seized all remaining supplies of the product to keep it off the market.

Like most cosmetic products, hair relaxers don’t require FDA approval before being sold. Manufacturers are responsible for ensuring their products are safe, and there are no federal regulations regarding these safety requirements.

CaseHair Relaxer Lawsuit: Case Details and Background

The Current Status of the Hair Relaxer Lawsuit

The hair relaxer cancer lawsuit continues to grow, with nearly 9,863 cases now combined into a multidistrict litigation (MDL) in the Northern District of Illinois. However, the total number of lawsuits filed is even higher—over 11,783—because some cases are still moving through state courts or haven’t been formally added to the MDL yet.

Despite the growing number of cases, manufacturers continue to deny liability and maintain that their products are safe. Companies like L’Oréal, Revlon, and Strength of Nature have repeatedly rejected claims that their chemical hair straighteners increase cancer risk. So far, none of the named manufacturers have agreed to a settlement, and they continue to challenge the lawsuits in court.

Defense attorneys argue that the scientific evidence linking hair relaxers to cancer is still inconclusive and that their products comply with existing cosmetic safety regulations. 

Manufacturers have also attempted to dismiss cases on procedural grounds, claiming that plaintiffs have not provided sufficient proof that hair relaxers directly caused their illnesses. However, federal judges have largely denied these dismissal attempts, allowing the lawsuits to proceed.

Despite these lawsuits moving forward, several legal challenges are slowing progress. Right now, attorneys for both sides are locked in discovery disputes involving internal company documents, expert testimony, and scientific evidence supporting the lawsuits’ central allegation. 

The lawsuit’s first bellwether trial is scheduled for November 3, 2025. The outcome of that trial is very likely to influence how future cases are resolved through settlements or more litigation.

Manufacturers’ Defense Tactics

Disputes Over Discovery

Before a trial begins, both sides of a lawsuit go through a process called discovery. In this process, each side asks the other for important documents, internal records, emails, and other pieces of evidence that could support their case. Plaintiffs want to see company documents that might show whether these companies knew their products were dangerous but failed to warn consumers. Manufacturers, on the other hand, want to keep as much of this information private as possible and have been pushing back hard against turning over their internal records.

In October 2023, all the companies being sued came together and submitted a legal argument saying the plaintiffs were asking for too much information. They claimed the requests were too broad and would require them to hand over documents that weren’t directly related to the case. 

This is a common tactic in lawsuits—companies try to limit the amount of information they can reveal, especially if it could damage their reputations or weaken their intended defense arguments.

Since the two sides couldn’t agree on the scope of discovery, the court had to intervene. In a hearing on October 30, 2024, the judge overseeing the case set strict deadlines for exchanging evidence.

• Written evidence (company documents, emails, medical records, etc.) must be collected and turned over by February 28, 2025.
• Witness testimony and interviews (where people from both sides answer questions under oath) must be completed by September 30, 2025.

To further help the progress of discovery, the court appointed Professor Maura R. Grossman as the Special Master to help oversee disputes about electronically stored information (ESI) that will be used as evidence.

At first, some manufacturers objected to appointing a Special Master, saying it wasn’t necessary. However, after discussions, both sides agreed on Professor Grossman for the role. Manufacturers did try to limit her fees by proposing a $10,000 monthly cap, arguing that the costs shouldn’t get out of control. Plaintiffs opposed the cap, saying it could interfere with her ability to manage the process.

As of February 2025, Professor Grossman is actively working to resolve disputes over evidence sharing and ensure the legal process stays fair and on track. 

These battles over discovery aren’t just legal technicalities—they could have a significant impact on the case. If plaintiffs access internal company documents, they might find proof that manufacturers knew their products contained harmful chemicals but didn’t warn consumers. On the other hand, if manufacturers successfully block some of these requests, it could make it harder for plaintiffs to prove their case.

The court’s role in managing these disputes is crucial. The more information plaintiffs can obtain, the stronger their case will be. The upcoming months will be critical as the court determines how much evidence must be disclosed and whether any companies attempted to conceal information.

Motions to Dismiss

Manufacturers have tried to get these lawsuits dismissed before trial by filing motions to dismiss, legal arguments claiming the cases shouldn’t proceed. So far, the court has rejected most of these efforts, allowing the lawsuits to proceed.

In July 2023, L’Oréal, Revlon, and other companies filed motions asking the court to dismiss the hair relaxer lawsuits. They argued that plaintiffs haven’t presented definitive proof that hair relaxers cause uterine, ovarian, or endometrial cancer. Their attorneys claimed that while some studies suggest a link, the science isn’t strong enough to prove causation and that the lawsuits should be dropped.

Manufacturers presented further arguments that federal cosmetic regulations should override state laws, meaning some of the claims against them shouldn’t be allowed in court. This is a common defense strategy in product liability cases—companies argue that they can’t be held liable under state law since they followed federal safety rules.

In response, Judge Mary Rowland ruled against most of the manufacturers’ arguments and denied their motions to dismiss. In November 2023, she found that plaintiffs had enough evidence to proceed with claims that the defendants failed to warn consumers about potential health risks. 

The judge also rejected the argument that federal regulations overrule state law claims, meaning those specific cases would continue to be heard in court.

Statutes of Limitations in the Hair Relaxer Lawsuit

When filing a lawsuit, you don’t have unlimited time. Every legal case is subject to a statute of limitations—a deadline that determines how long you have to take legal action. Once that deadline passes, you lose the right to file a lawsuit, no matter how strong your case is.

In hair relaxer lawsuits, the statute of limitations varies depending on the state in which you live. Some states give you only a few years from your diagnosis, while others may allow more time. However, these deadlines aren’t always straightforward. They can depend on:

• When you were diagnosed with cancer.
• When you first realized that your illness might have been caused by using hair relaxers.
• State-specific laws that determine how statutes of limitations apply in product liability cases.

Don’t Wait—Find Out if You Qualify

Understanding how statutes of limitations apply to your case can be complicated, but Tosi Law can help. Our in-house case counselors are available to review the specifics of your case and determine whether you’re eligible to file a claim.

If you or a loved one has been diagnosed with uterine, ovarian, or endometrial cancer after using chemical hair relaxers, contact us today for a free case evaluation. 

The sooner you act, the better your chances of securing justice and compensation.

Hair Relaxer Lawsuit Compensation and Payouts

If you’ve been diagnosed with uterine, ovarian, or endometrial cancer after using chemical hair relaxers, you might be wondering what kind of compensation could be available. While it’s too early to predict specific payout amounts, lawsuits like these generally seek compensation for medical expenses, lost income, pain and suffering, and other damages.

Factors Influencing Compensation in Hair Relaxer Lawsuits

Since every case is different, potential compensation depends on several factors, including:

• The severity of your illness. The type and stage of cancer, as well as the impact it has had on your daily life, will likely be considered.
• Your history of hair relaxer use. How long and how frequently you used chemical hair relaxers may be an essential factor.
• Medical costs and treatment. Expenses related to hospital visits, surgeries, chemotherapy, and other treatments may be included.
• Lost wages and financial impact. If your illness has affected your ability to work, that could play a role in determining potential compensation.
• Legal and scientific developments. As the lawsuits progress, new evidence or legal rulings may impact how compensation is calculated.

Since these lawsuits are still in progress, it’s vital to stay informed and consult with legal professionals to understand your options.

Who is Eligible for Hair Relaxer Compensation?

If you or a loved one has been diagnosed with uterine, ovarian, or endometrial cancer after using chemical hair relaxers, you may be eligible to take legal action.

In most cases, eligibility will depend on:

• A confirmed diagnosis of one of the cancers linked to hair relaxers.
• A history of using chemical hair relaxers over a period of time.
• Meeting the statute of limitations based on your state’s laws.

If you’re unsure whether you qualify, speaking with a legal team can help determine your next steps. Tosi Law has in-house case counselors who can assess your situation and provide guidance on your legal options.

If you think your cancer diagnosis may be linked to hair relaxers, contact us today for a free case evaluation.

Filing a Hair Relaxer Lawsuit

Establishing Your Eligibility for a Hair Relaxer Lawsuit

To file a hair relaxer lawsuit, you must show that you used chemical hair relaxers for an extended period of time and were later diagnosed with uterine, ovarian, or endometrial cancer. 

To support these claims, you would need to provide your medical history and evidence showing that you used these products.

For some people, proving their history of hair relaxer use may seem difficult, especially if they didn’t keep any purchasing records. However, eligibility doesn’t always require receipts or direct proof. Testimony from friends, family members, or hairstylists can help confirm your history of using these products.

Because eligibility in product liability lawsuits can be complex, it is extremely important to speak with a legal professional. Tosi Law has a dedicated team of in-house case counselors who can assess your situation and determine whether you qualify.

If you believe your cancer diagnosis is linked to hair relaxers, contact us today for a free case evaluation.

Is There a Time Limit to Filing a Hair Relaxer Lawsuit?

Yes, there is a statute of limitations that sets a deadline for filing a hair relaxer lawsuit. The exact time limit depends on where you live, as different states have different legal deadlines. Some states allow only a few years after diagnosis to file a claim, while others allow more time.

Figuring out when your deadline begins can be complicated. It may be based on when you were first diagnosed, or when you first suspected that your illness was linked to hair relaxer use. While there are some exceptions that may apply to your case, it’s very important to note that missing the filing deadline would prevent you from filing a lawsuit, no matter how strong your case is.

Since these laws vary from state to state, it’s crucial to act quickly. Tosi Law can help you determine the time limits that apply to your case so you don’t lose your opportunity to take legal action.

How Much Does it Cost to Hire a Law Firm?

Filing a lawsuit can seem financially intimidating, but Tosi Law operates on a contingency fee basis—which means there are no upfront costs to start your case. You only pay if you win a settlement or court verdict, and if there is no recovery, you owe nothing.

This arrangement ensures that anyone affected by hair relaxer-related health issues has access to legal representation, regardless of their financial situation. It allows plaintiffs to focus on their health while their legal team fights for justice.

If you have questions about legal fees, Tosi Law is happy to provide clear, upfront answers.

Contact us today to learn more.

How to Choose the Right Lawyer for a Hair Relaxer Lawsuit

Choosing the right lawyer is one of the most important decisions you’ll make in your case. Not all law firms have the experience, resources, or focus required to take on major corporations in product liability lawsuits.

Before hiring an attorney, consider their background in handling cases like these. Have they worked on product liability lawsuits before? Do they have experience in mass tort cases? These lawsuits often require collaboration with scientific experts, medical professionals, and industry specialists, so working with a firm that has the right network is essential.

It’s also important to choose a legal team that prioritizes clear communication. Lawsuits can take time, and you’ll want a firm that keeps you informed and answers your questions throughout the process. A good attorney should make the experience as straightforward and stress-free as possible while advocating for your best interests.

At Tosi Law, we are committed to providing expert legal representation and compassionate client support. We will guide you through every step of the process and ensure that your case receives the attention it deserves.

Speak to Tosi Law About Filing a Hair Relaxer Lawsuit

If you’ve been diagnosed with uterine, ovarian, or endometrial cancer after long-term use of chemical hair relaxers, you may have grounds for legal action.

At Tosi Law, we have a dedicated team of case counselors ready to evaluate your situation, answer your questions, and determine if you’re eligible to file a claim. We handle all aspects of the legal process, from gathering evidence to representing clients in court—and we do it all with no upfront costs.

Your time to file a lawsuit may be limited, so don’t wait. Contact Tosi Law today for a free case evaluation and learn more about your legal options.

Call Tosi Law if You Have Questions

If you or a loved one has developed multiple myeloma or any other type of cancer after being exposed to Roundup, you could be entitled to compensation. Please call Tosi Law LLP at 888-311-8292 for more information. Our defective product lawyers are ready to help you file a Roundup lawsuit.

Call Today

FAQs

1. What is the basis for hair relaxer cancer lawsuits?

Recent scientific studies have identified a potential link between prolonged use of chemical hair relaxers and an increased risk of certain cancers, particularly uterine and ovarian cancers. These lawsuits allege that manufacturers failed to warn consumers about these risks despite being aware or reasonably expected to be aware of the potential dangers associated with their products.

2. Who is eligible to file a hair relaxer lawsuit?

Individuals who have regularly used chemical hair straightening or relaxing products and have been diagnosed with uterine, ovarian, or endometrial cancer may be eligible to file a lawsuit. Eligibility often requires a history of consistent product use and a medical diagnosis linking the illness to these products.

3. What compensation might be available in a hair relaxer lawsuit?

Compensation in a hair relaxer lawsuit may cover medical expenses, lost wages, and pain and suffering. The amount depends on factors like the severity of the illness, the impact on daily life, and the cost of medical treatments. Since every case is different, consulting a legal professional is the best way to understand what compensation may be available.

4. How long do I have to file a hair relaxer lawsuit?

The timeframe to file a lawsuit, known as the statute of limitations, varies by state. Generally, it ranges from one to six years from the date of diagnosis or from when the connection between the product use and the illness was discovered. Due to these varying deadlines, it’s crucial to seek legal advice promptly to ensure your claim is filed within the applicable timeframe.

5. Are there ongoing class-action lawsuits related to hair relaxers?

Yes, there are ongoing legal actions concerning hair relaxer products. In September 2024, a federal judge allowed a proposed class-action lawsuit to proceed against major manufacturers like L’Oréal and Revlon. This lawsuit seeks reimbursement for consumers who purchased these products without being informed of the potential cancer risks.

6. What evidence is needed to support a hair relaxer lawsuit?

A strong lawsuit requires medical records confirming a cancer diagnosis, proof of hair relaxer use, and, in some cases, expert testimony linking the product to the illness. Receipts, doctor’s notes, or testimony from family and hairstylists can help establish product use. A legal team can assist in gathering the necessary documentation.